期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

重组人促红细胞生成素在肾性贫血中合理应用的专家共识 被引量：107

Rational application of recombinant human erythropoietin to renal anemia, the specialist＇s general understanding
下载PDF
导出
摘要 肾性贫血是慢性肾脏病的重要临床表现,是慢性肾脏病患者合并心血管并发症的独立危险因素,有效治疗肾性贫血是慢性肾脏病一体化治疗的重要组成部分.
作者 陈香美 孙雪峰 蔡广研
机构地区 解放军总医院全军肾脏病研究所
出处 《中国血液净化》 2007年第8期440-443,共4页 Chinese Journal of Blood Purification
关键词 重组人促红细胞生成素 肾性贫血 慢性肾脏病 专家 独立危险因素 心血管并发症 一体化治疗 临床表现
分类号 R453 [医药卫生—治疗学]
  • 相关文献

参考文献13

  • 1Clinical practice guidelines and Clinical practice recommendations for animia in chronic kidney disease in adults[J].American Journal of Kidney Diseases,2006,47(Suppl 3):S16-S85.
  • 2Clinical practice recommendations for animia in chronic kidney disease in transplant recipients[J],American Journal of Kidney Diseases,2006,47(Suppl 3):S109-Sl16.
  • 3Panletti E,Cannella G.Update on erythropoietin treatment:should hemoglobin be normalized in patients with chronic kidney disease[J].J Am Soc Nephrol,2006,17(Suppl 2):S74-S77.
  • 4倪兆慧,钱家麒,丁小强,梅长林,袁伟杰,张金元,陈江华,邢昌赢,刘必成.蔗糖铁注射液治疗维持性血液透析患者肾性贫血的前瞻性、随机对照多中心研究[J].中华肾脏病杂志,2006,22(3):143-148. 被引量：113
  • 5Chatterjee PK.Pleiotropic renal actions of erythropoietin[J].Lancet,2005,365(9474):1890-1892.
  • 6Revised European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure[J].Nephrol Dial Transplant,2004,19(Suppl 2):ii1-ii47.
  • 7袁群生,郑法雷,丁峰,姜筠,郭王,黄峰先,王质刚,余学清,谌贻璞,顾勇,单渊东.蔗糖铁注射液治疗血液透析患者肾性贫血的多中心研究[J].中华肾脏病杂志,2004,20(1):51-55. 被引量：117
  • 8Collins AJ.Anaemia management prior to dialysis:cardiovascular and cost-benefit observations[J].Nephrol Dial Transplant,2003,18 (Suppl 2)::2-6.
  • 9de Francisco AL,Fernandez Fresnedo G,et al.Past,present and future of erythropoietin use in the elderly[J].Int Urol Nephrol,2002,33(1):187-193.
  • 10郑法雷,李莉,谌贻璞,陈香美,王质刚,唐政,陆福明,王梅,于仲元.应用重组人红细胞生成素注射液(宁红欣)治疗肾性贫血的多中心临床试验报告[J].中国血液净化,2002,1(5):5-8. 被引量：16

二级参考文献52

  • 1季曙明,黎磊石.应用重组促红细胞生成素治疗长期血透患者贫血[J].中华内科杂志,1993,32(2):100-102. 被引量：6
  • 2郑法雷,毕增祺.小剂量红细胞生成素对透析前慢性肾衰患者贫血的作用[J].中华内科杂志,1993,32(7):440-443. 被引量：8
  • 3蔡美顺 译.关于慢性肾功能衰竭贫血治疗临床指南[J].中国血液净化,2000,(3):235-235.
  • 4[1]Winearls CG. Recombinant human erythropoietin: 10 years of clinical experience. Nephrol Dial Transplant, 1998, 13(Suppl 2):3-8
  • 5[2]Wagstaff AJ. Epoetin alfa. A review of its clinical efficacy in the management of anaemia associated with renal failure and chronic disease and its use in surgical patients. Drugs Aging,1995, 7(2):131-56
  • 6[3]House AA, Pham B,Pag DE. Transfusion and recombinant human erythropoietin requirements differ between dialysis modalities. Nephrol Dial Transplant, 1996, 13(7):1763-9
  • 7[4]Jones MA,Kingswood JC,Dallyn PE, et al. Haemodynamic changes measured by transthoracic bioimpedance during treatment with recombinant human erythropoietin. Clin Exp Hypertens ,1996, 18(1):51-64
  • 8[5]Sundal E,Kaeser U.Correction of anaemia of chronic renal failure with recombinant human erythropoietin:safety and efficacy of one year's treatment in a European Multicentre Study of 150 haemodiaysis-dependent patients.Nephrol Dial Transplant,1989,4:979-987
  • 9[6]Parker KP,Mitch WE, Stivelman JC, et al. Safety and efficacy of low-dose subcutaneous erythropoietin in hemodiaysis patients. J Am Soc Nephrol,1997,8:288-293
  • 10[7]Eschbanh JW.The anemia of chronic renal failure:Pathophysiology and effects of recombinant erythropoietin. Kidney Int,1989,35:134-148

共引文献258

同被引文献842

引证文献107

二级引证文献894

中国血液净化
2007年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部